Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CFO and CBO

General Counsel & Corp. Sec.

Chairman & CEO

Chief Medical Officer

Chief Financial Officer

Chairman and CEO

See Remarks

General Counsel

Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. It is also developing ERAS-801, a central nervous system-penetrant EGFR inhibitor for the treatment of patients with recurrent glioblastoma multiforme. The company was incorporated in 2018 and is headquartered in San Diego, California.

Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients w...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-12-15	Premium	acquired	Premium	Premium	Premium	CFO and CBO
2023-12-15	Premium	acquired	Premium	Premium	Premium	General Counsel & Corp. Sec.
2023-12-06	Premium	bought	Premium	Premium	Premium	-
2023-12-06	Premium	bought	Premium	Premium	Premium	Chairman & CEO
2023-12-05	Premium	bought	Premium	Premium	Premium	Chairman & CEO
2023-12-04	Premium	bought	Premium	Premium	Premium	-
2023-10-05	Premium	bought	Premium	Premium	Premium	Chairman & CEO
2023-06-08	Premium	bought	Premium	Premium	Premium	Chairman & CEO
2023-04-10	Premium	bought	Premium	Premium	Premium	-
2023-03-28	Premium	bought	Premium	Premium	Premium	Chairman & CEO
2023-02-01	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-02-01	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-02-01	Premium	acquired	Premium	Premium	Premium	General Counsel & Corp. Sec.
2023-01-10	Premium	bought	Premium	Premium	Premium	Chairman & CEO
2022-12-21	Premium	bought	Premium	Premium	Premium	-
2022-12-21	Premium	bought	Premium	Premium	Premium	-
2022-12-15	Premium	bought	Premium	Premium	Premium	-
2022-12-14	Premium	bought	Premium	Premium	Premium	Chairman & CEO
2022-12-13	Premium	bought	Premium	Premium	Premium	-
2022-11-30	Premium	gifted	Premium	Premium	Premium	Chairman and CEO
2022-07-01	Premium	sold	Premium	Premium	Premium	-
2022-02-01	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2022-02-01	Premium	acquired	Premium	Premium	Premium	General Counsel & Corp. Sec.
2022-02-01	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer

ERAS - Erasca, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for ERAS